Últimas noticias sobre Polestar Automotive (NASDAQ:PSNY) Bolsa

Polestar Automotive

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.

Equities

News

Markets

General

ARKX

PSNY

Polestar registra un aumento del 5,3% en las ventas al por menor en el 4T de 2024, pero reporta una caída del 15% en el total anual.

Ventas de Polestar aumentan 5,3% en el 4T, pero caen un 15% en 2024

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive Holding UK PLC

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Across the recent three months, 10 analysts have shared their insights on Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $37.4, a high estimate of $44.00, and a low estimate of $30.00. Experiencing a 2.35% decline, the current average is now lower than the previous average price target of $38.30. 
<img src="https://www.benzinga.com/files/images/story/2025/1736514040_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Warner Music Gr by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Batya Levi</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$41.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Vijay Jayant</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Michael Morris</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Michael Morris</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$44.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Jason Bazinet</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Alan Gould</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$35.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Tim Nollen</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Michael Morris</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$44.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>David Karnovsky</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$40.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Kannan Venkateshwar</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Warner Music Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Warner Music Gr compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Warner Music Gr's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Warner Music Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WMG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Warner Music Gr analyst ratings.</a>
<h2>All You Need to Know About Warner Music Gr</h2>
Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappel controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.
<h3>Financial Insights: Warner Music Gr</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Warner Music Gr showcased positive performance, achieving a revenue growth rate of 2.77% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Warner Music Gr's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.52%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Warner Music Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 8.19%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.46%, the company showcases effective utilization of assets.
Debt Management: Warner Music Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 8.28.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

10 Analysts Have This To Say About Warner Music Gr

8 analysts have shared their evaluations of Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $67.38, with a high estimate of $78.00 and a low estimate of $60.00. This upward trend is evident, with the current average reflecting a 8.38% increase from the previous average price target of $62.17.
<img src="https://www.benzinga.com/files/images/story/2025/1736514025_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Avidity Biosciences by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Announces</td>
<td>Buy</td>
<td>$72.00</td>
<td>-</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$67.00</td>
<td>-</td>
</tr>
<tr>
<td>Keay Nakae</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$65.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Keay Nakae</td>
<td>Chardan Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ritu Baral</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$56.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Avidity Biosciences. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Avidity Biosciences compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Avidity Biosciences's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Avidity Biosciences's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RNA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Avidity Biosciences analyst ratings.</a>
<h2>Discovering Avidity Biosciences: A Closer Look</h2>
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
<h3>Financial Insights: Avidity Biosciences</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Avidity Biosciences's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -17.1% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -3441.7%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Avidity Biosciences's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -5.9%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Avidity Biosciences's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -5.38%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Avidity Biosciences's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Avidity Biosciences's Future

BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), the world&#8217;s largest asset manager with $11.5 trillion in assets, has withdrawn from the Net Zero Asset Managers initiative, a global group committed to achieving net zero greenhouse gas emissions by 2050 or sooner, following President-elect Donald Trump&#8216;s victory and increasing regulatory pressure.
In a letter to institutional clients, Vice-Chair Philipp Hildebrand cited regulatory inquiries and client confusion as key factors driving the decision, the Financial Times <a href="https://www.ft.com/content/f0fb9841-db1d-442e-a757-1a1327497fb1">reported</a> on Thursday. 
The move follows similar <a href="https://www.benzinga.com/government/regulations/25/01/42770035/bank-of-america-citigroup-exit-climate-alliance-as-trump-policies-shift-energy-priorities">exits by major U.S. banks, </a>including JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), from climate alliances.
BlackRock&#8217;s environmental proxy voting support has declined significantly, dropping from 47% in 2021 to 4% last year, reflecting a broader shift in its climate stance. The firm maintains this decision won&#8217;t alter its approach to climate risk assessment in portfolio management, even as it faces ongoing litigation from 11 Republican-led states regarding its environmental policies.
Meanwhile, the Trump administration aims to <a href="https://www.benzinga.com/markets/commodities/24/11/42235640/trumps-energy-policies-poised-to-reshape-oil-gas-market-winners-and-losers-revealed">boost energy production by 3 million barrels </a>of oil equivalent per day, introduce a potential 25% tariff on Canadian oil and gas imports, and expedite the approval process for liquefied natural gas (LNG) exports.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42904377/tesla-bull-gary-black-warns-against-inflated-optimus-robot-assumptions-get-pounded-each-time-i-try-to-right-size-expectations">Tesla Bull Gary Black Warns Against Inflated Optimus Robot Assumptions: Get Pounded Each Time &#8216;I Try To Right-Size Expectations&#8217;</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump Fallout? BlackRock Exits Climate Alliance, Cites Regulatory Pressure And Client Confusion

Deutsche Bank analyst Omotayo Okusanya upgrades CubeSmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBE#NYSE">CUBE</a>) from Sell to Hold and lowers the price target from $46 to $45.

Upgrades

Price Target

CUBE

Deutsche Bank Upgrades CubeSmart to Hold, Lowers Price Target to $45

D. Boral Capital analyst Jason Kolbert maintains Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) with a Buy and maintains $9 price target.

IVVD

D. Boral Capital Maintains Buy on Invivyd, Maintains $9 Price Target

JFBR

Jeffs' Brands Estimates Its Revenues For The Year Ended December 31, 2024 To Exceed $13M, Reflecting An Approximately 30% YoY Growth; Anticipates over 120% Revenue Growth Since Its IPO In 2022

American Electric Power Company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) shares are trading higher in premarket Friday.
The company announced that a 50/50 strategic partnership between KKR &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) and PSP Investments has agreed to acquire&nbsp;19.9%&nbsp;non-controlling equity interest in its Ohio&nbsp;and&nbsp;Indiana&nbsp;&amp; Michigan Transmission Companies <a target="_blank" href="https://www.benzinga.com//node/42901587" rel="noreferrer noopener">(Transcos)&nbsp;for&nbsp;$2.82 billion.</a>
The deal is expected to boost AEP&#8217;s ability to finance its $54 billion capital investment plan over the next five years.
The partnership will also allow AEP to improve the reliability of its transmission infrastructure and strengthen its balance sheet, to meet growing customer demand in the Midwest.
The stake acquired represents roughly 5% of AEP&#8217;s overall transmission rate base. The capital raised through this transaction will fund key projects across transmission, distribution, and generation, helping AEP manage its equity financing requirements through 2029.
&#8220;Executing on our five-year capital plan is critical to meeting growing energy demand and bolstering reliability for our customers. Electricity demand is anticipated to grow significantly in AEP&#8217;s footprint by the end of the decade,&#8221; said&nbsp;Bill Fehrman,&#8221; said AEP President and CEO Bill Fehrman.
&#8220;KKR and PSP Investments are experienced investors in the utilities and energy space with a proven track record of successful infrastructure investments.&#8221;
The transaction is expected to be completed in the second half of 2025 and is said to immediately benefit AEP&#8217;s earnings.
The agreement requires approval from FERC and clearance from the Committee on Foreign Investment in&nbsp;the U.S.
Price Action: AEP shares are trading higher by 0.81% at $93.01 in premarket at the last check Friday.
Photo via Shutterstock.

Asset Sales

Movers

American Electric Power Sells 19.9% Stake In Two Transmission Assets For $2.82B: Details

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $128 price target.

BMEA

D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $128 Price Target

ESSA

Trading Halt: Halt status updated at 7:55:00 AM ET: Quotation Resumption: News and Resumption Times

Northland Capital Markets analyst Ted Jackson maintains Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) with a Outperform and raises the price target from $4 to $10.

AMPX

Northland Capital Markets Maintains Outperform on Amprius Technologies, Raises Price Target to $10

Guidance

ETWO

E2open Trims FY25 Revenue Outlook To $607M - $611M From $607M - $617M

Northland Capital Markets analyst Mike Grondahl maintains Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) with a Outperform and raises the price target from $20 to $24.

BTDR

Northland Capital Markets Maintains Outperform on Bitdeer Technologies, Raises Price Target to $24

Wells Fargo analyst Ike Boruchow downgrades Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) from Overweight to Equal-Weight and maintains the price target from $165 to $165.

Downgrades

ROST

Wells Fargo Downgrades Ross Stores to Equal-Weight, Maintains Price Target to $165

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) co-founder Joe Lonsdale offered a sobering assessment of the Department of Government Efficiency initiative, suggesting that while $1 trillion in federal spending cuts might be achievable, further reductions would face significant hurdles.
What Happened: &#8220;The next trillion will be a lot harder,&#8221; Lonsdale said during a CNBC <a href="https://www.youtube.com/watch?v=RBAGWBQNogU">interview</a> on Thursday, tempering expectations for the ambitious cost-cutting program championed by Tesla Inc. CEO Elon Musk. The initiative, which initially targeted $2 trillion in cuts, has recently scaled back its goals.
Lonsdale revealed that the effort has attracted significant talent, noting, &#8220;I know dozens of friends who are helping out in various ways—brilliant engineers and lawyers working day and night.&#8221; However, he emphasized that government resistance and bureaucratic obstacles would make deeper cuts challenging.
The discussion gains particular significance as President-elect Donald Trump&#8216;s team plans to integrate DOGE into a second administration. 
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/42904377/tesla-bull-gary-black-warns-against-inflated-optimus-robot-assumptions-get-pounded-each-time-i-try-to-right-size-expectations">Tesla Bull Gary Black Warns Against Inflated Optimus Robot Assumptions: Get Pounded Each Time &#8216;I Try To Right-Size Expectations&#8217;</a>
Why It Matters: Lonsdale, who <a href="https://www.benzinga.com/markets/equities/24/09/40786654/elon-musk-invites-joe-lonsdale-to-join-d-o-g-e-but-palantir-founder-points-out-failure-of-simila">previously attempted similar efficiency initiatives</a> during the former President Barack Obama&#8216;s administration, shared a cautionary tale: &#8220;Obama even verbally agreed to let us do it back in the day but then his people stopped it from going ahead; wasn&#8217;t politically useful to find all that for some reason.&#8221;
Analyzing potential savings areas, Lonsdale identified fraud reduction, entitlement reform, and elimination of unused government buildings as promising targets. However, he expressed skepticism about substantial defense spending cuts, citing strong bipartisan support in Congressional committees and national security considerations.
The initiative&#8217;s evolution reflects growing attention to government efficiency as Trump has appointed Musk to lead a commission auditing federal agencies. This alignment of technology leaders with government reform efforts marks a significant shift in approaches to <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">federal spending reduction</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42906328/crypto-fear-and-greed-index-hits-lowest-level-since-october-as-bitcoin-falls-under-92k-dogecoin-and-shiba-inu-trade-in-red">Crypto Fear And Greed Index Hits Lowest Level Since October As Bitcoin Falls Under $92K, Dogecoin And Shiba Inu Trade In Red</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Global

PLTR

TSLA

Palantir Co-Founder Joe Lonsdale Sets Realistic Expectations For Elon Musk's DOGE Initiative: 'Next Trillion Will Be A Lot Harder'

Wells Fargo analyst Ike Boruchow upgrades Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) from Equal-Weight to Overweight and raises the price target from $20 to $28.

CPRI

Wells Fargo Upgrades Capri Holdings to Overweight, Raises Price Target to $28

E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) reported quarterly adjusted earnings of $0.05 per share which met the analyst consensus estimate. This is a 25 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $151.65 million which missed the analyst consensus estimate of $152.63 million by 0.64 percent. This is a 3.04 percent decrease over sales of $156.40 million the same period last year.

Earnings

Earnings Misses

E2open Parent Holdings Q3 Adj $0.05, Inline, Sales $151.65M Miss $152.63M Estimate

Ivory Hill Wealth founder Kurt S. Altrichter predicts three possible scenarios how markets could react following today&#8217;s unemployment data report. 
What Happened: In a thread posted on X on Jan. 8, Altrichter <a href="https://x.com/kurtsaltrichter/status/1877048144350806104?s=46">outlined</a> three potential scenarios:
<ul>
<li>A &#8220;too hot&#8221; report triggering a market selloff.</li>
<li>A &#8220;just right&#8221; report sparking a broad relief rally.</li>
<li>A &#8220;too cold&#8221; report initially boosting markets before concerns arise over economic growth.</li>
</ul>
These vastly different outcomes highlight the significant volatility expected in response to the upcoming data release.
A &#8220;too hot&#8221; outcome, characterized by over 200,000 jobs added and unemployment dipping below 4.1%, is expected to trigger a notable selloff. 
Equities would fall over 1%, with Treasury yields spiking toward 5%, thereby pressuring stocks.
Although Altrichter does not specifically mention cryptocurrencies, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) would likely follow stocks lower if his prediction turned out to be correct.
Conversely, a &#8220;just right&#8221; scenario, with 50,000 to 200,000 new jobs, unemployment between 4.1% and 4.3%, and wage growth at or below 4.0%, would spark a broad relief rally. 
This would include modest gains across all indices, with tech and small-caps leading the way. Both asset classes tend to be correlated with cryptocurrencies.
In the case of a &#8220;too cold&#8221; report, featuring fewer than 50,000 jobs added and unemployment exceeding 4.3%, the initial reaction would be a rally driven by expectations of rate cuts. 
However, growth concerns would then quickly take over, placing pressure on cyclical sectors.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42894427/bitcoin-ethereum-etfs-see-742-million-in-outflows-supply-shock-unlikely-in-2025-report-shows">Bitcoin, Ethereum ETFs See $742 Million In Outflows, Supply Shock Unlikely In 2025, Report Shows</a>
Why It Matters: The founder of Ivory Hill Wealth emphasized that markets are on edge and that a "too hot" outcome represents the largest risk, due to the possibility of Treasury yields reaching 5%, amplifying a broad selloff.
Altrichter suggested that a "Goldilocks" number, between 100,000 and 125,000 new jobs, would serve as the best outcome for calming Fed fears and initiating a solid relief rally.
Under the &#8220;too hot&#8221; scenario, small-cap stocks would lead declines, while technology and industrial sectors would only slightly outperform other sectors.
Gold would fall due to a stronger dollar and oil would hold up due to demand expectations.
Under a &#8220;just right&#8221; scenario, Treasury yields would drop approximately 10 basis points, weakening the dollar slightly, and gold would rally, with most sectors rising with tech, financials, cyclicals — and likely cryptocurrencies — leading.
In the "too cold" scenario, Treasury yields would drop sharply, while the dollar would weaken significantly, causing a notable gold rally; defensive sectors would outperform, helping to cushion overall market losses while cyclicals would lag behind.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42885028/gary-gensler-says-10000-15000-projects-wont-survive-crypto-market-is-wrapped-up-in-sentiment">Gary Gensler Says 10,000-15,000 Projects Won&#8217;t Survive, Crypto Market Is &#8216;Wrapped Up In Sentiment&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Previewing Today's 'Most Important Jobs Report' — What It Means For Bitcoin

IONQ

IonQ Sees 2024 Results At The High End Of Bookings And Revenue Guidance; Company Sees Sales Approaching $1B By 2030.

Wells Fargo analyst Ike Boruchow upgrades Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Equal-Weight to Overweight and raises the price target from $42 to $48.

BBWI

Wells Fargo Upgrades Bath & Body Works to Overweight, Raises Price Target to $48

Wells Fargo initiates coverage on Maplebear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) with a Equal-Weight rating and announces Price Target of $47.

Initiation

CART

Wells Fargo Initiates Coverage On Maplebear with Equal-Weight Rating, Announces Price Target of $47

Electric vehicle stocks rip big gains after Beijing developments

Polestar (PSNY) has appointed Jonas Engstrom to the role of COO. As COO, Engstrom's main focus will be the delivery of Polestar's growing car progr...

Polestar appoints Jonas Engstrom COO

Polestar names Jonas Engström as COO

Catalyst Watch: Eyes on electric vehicle deliveries, retail data and housing reads

Tesla: Major Q4 Delivery Disappointment

In a report released today, Daniel Roeska from Bernstein maintained a Sell rating on Polestar Automotive Holding UK (PSNY – Research Report), with ...

Polestar Automotive Holding UK (PSNY) Receives a Sell from Bernstein

2025 Analyst Outlook: Chris Lau On Tariffs, Global Worries, EVs, And An AI Bubble

EV Company News For The Month Of December 2024

Polestar (PSNY) announced retail sales totaled 12,256 cars in Q4 2024, up 5.3% versus Q4 2023, taking total retail sales for the full year to 44,85...

Polestar reports Q4 retail sales up 5.3% to 12,256 cars

Polestar Automotive reports a Q4 increase in retail sales and order intake

ABAT

ASML

ATRA

AVGO

AYRO

BABA

BATT

BCCMY

BLBD

BLNK

BMCLF

BYDDF

BYDDY

BYND

CHPT

CRVO

DNFGF

DNFGY

DRIV

EVTV

FUJHF

FUJHY

FYBR

GELYF

GELYY

GOEV

GOEVW

GWLLF

GWLLY

HNDAF

HOUR

HYLN

HYMTF

IDRV

IIPR

INTC

KARS

KNDI

KULR

KWEB

LAAOF

LAZR

LCID

LPTH

LPTX

MAHMF

MBGAF

MBGYY

MBLY

MESO

MMTOF

MZDAF

MZDAY

NIOIF

NSANF

NSANY

NVDA

POAHF

POAHY

PSNYW

QUBT

RACE

RGTI

RIVN

RNLSY

RNSDF

SGOV

STLA

SWTX

SZKMF

SZKMY

TECK

TOYOF

VALE

VFSWW

VLKAF

VLKPF

VWAGY

VWAPY

WKHS

XIACF

XIACY

XPEV

XPNGF

Press Releases

Polestar Publishes Q2 2024 Results: 82% Growth in Global Deliveries

Polestar appoints Jean-Francois Mady as CFO

Polestar Announces Date of AGM and Board Changes

Polestar Fully Compliant With Nasdaq Listing Rules

Infosys and Polestar Enter Strategic Collaboration by opening Technology Hub in Bengaluru, India

Polestar Announces Global Volumes for the Third Quarter; to Provide Business and Strategy Update on 16 January 2025

Polestar Now Offers Its Customers Access to One of the World's Largest Charging Networks

Polestar Delivers First Polestar 3 Manufactured in U.S. to North American Customers

Polestar Appoints Jonas Engström Chief Operating Officer

Polestar Announces Global Volumes for the Fourth Quarter

INFY

NIO Inc. American depositary shares, each representing one Class A ordinary share

Comments

Polestar Automotive

Noticias

Últimas noticias sobre Polestar Automotive (NASDAQ:PSNY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL